A randomized controlled clinical trial of cefoperazone/sulbactam

Zhng Ye

Chinese Pharmaceutical Journal ›› 1999, Vol. 34 ›› Issue (10) : 703-705.

Chinese Pharmaceutical Journal ›› 1999, Vol. 34 ›› Issue (10) : 703-705.
药物与临床

A randomized controlled clinical trial of cefoperazone/sulbactam

  • Zhang Ye
Author information +
History +

Abstract

OBJECTIVE:To evaluate the efficacy and safety of cefoperazone/sulbactam in the treatment of bacterial infections.METHODS:60 patients with infection were enrolled in a randomized controlled open clinical trial.RESULTS:In the randomized controlled group,the overall clinical efficacy rates of cefoperazone/sulbactam and cefotaxime were 95.51% and 90.5% respectively,the bacteriological response were 95.23% and 90.0% respectively,the rates of adverse drug reaction were 9.09% and 9.52% respectively.There was no significant difference between the two groups.In the open group,the clinical efficacy rate,the bacteriological eradication and the rate of adverse drug reaction of cefoperazone/sulbactam was 95.33%,87,5% and 12.0% respectively. The susceptibility rates of the bacteria isolated to cefoperazone/sulbactam and cefotaxime were similar.CONCLUSIONS:cefoperazone/sulbactam is highly effective and well tolerated.

Key words

cefoperazone/sulbactam / cefotaxime / randomized controlled / clinical trial

Cite this article

Download Citations
Zhng Ye. A randomized controlled clinical trial of cefoperazone/sulbactam[J]. Chinese Pharmaceutical Journal, 1999, 34(10): 703-705

References

1 Bodey GP,Ehing LS,Narm J,el a1.An open trial of cefoperazone plus sulbactam for the treamaent of fever in cancer patients.J Antimicrob Chemther,1993,32(1):141. 2 Hara K,Saito A,Suzuyama Y,el a1.Wdl controlled comparative clinical trial of sulbactam/cefoperazone(SBT/CPZ) and cefotaxime(CTX) in the treatment of respiratory infections.Chemother,1985,33(1):184. 3 lshibashi T,Takamota M,Shinoda A.el a1.Clinical evaluation of snlbactam/cefoperazone in lower respiratory tract infections.J Antibiot (Tokyo),1990,43(2):239. 4 Motojima S,isakawa J,Ezure M,et a1.Multicenter study of the effects of sulbactam/cefoperazone On bacterial infections in the field of intemal medicine focused mainly on respiratory infections in Tochigi prefecture.JAntibiot (Tokyo),1993,46(10):918. 5 Kawada Y.Kanematsu M,Nishura T,et a1.Singificance of combination of sulbactam and cefoperazone in the treatment of complicated urinary tract infection.Chemother,1984,32(S-4):625. 6 Jones Ran,Barry AL.Cefoperazone:review of its antimicmbial spectrum,Beta-lactamase stability,enzyme inhibition,and other in vitro characteristics.Rev Infect Dis,1983,5(Supple):108. 7 Jones RN.Barry AL,Thomsbery C,el a1.The cefoperzone-snlbactam combintion:in vitro qualities including heta-lactamase stability,antimicrobial activity,and interpretive criteria for disk diffusion tests.AJ CP,1985,84(4):496. 8 Jones RN,Wilson HW,Thomsberry C,el a1.In vitro antimiembial activity of cefoperazone-sulbactam combinations against 554 elinical isolates including a review and beta-lactamase studies.Diagn Microbial Infect Dis,1985,3(6):489.

37

Accesses

0

Citation

Detail

Sections
Recommended

/